Quantity and quality of mental activities and the risk of incident mild cognitive impairment.


Journal

Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060

Informations de publication

Date de publication:
06 08 2019
Historique:
received: 27 11 2018
accepted: 28 03 2019
pubmed: 12 7 2019
medline: 7 1 2020
entrez: 12 7 2019
Statut: ppublish

Résumé

To investigate whether timing, number, and frequency of mentally stimulating activities in midlife and late life are associated with the risk of incident mild cognitive impairment (MCI). We conducted a prospective cohort study in the setting of the population-based Mayo Clinic Study of Aging in Olmsted County, Minnesota, including 2,000 individuals aged ≥70 years who were cognitively unimpaired at baseline and were followed for a median of 5.0 years. Participants completed a self-reported survey on timing, number, and frequency of engagement in 5 mentally stimulating activities (reading books, computer use, social activities, playing games, craft activities) at baseline. The risk of incident MCI was significantly reduced for participants who engaged in social activities (hazard ratio [95% confidence interval] 0.80 [0.64-0.99]) and playing games (0.80 [0.66-0.98]) in both late life and midlife combined. Using a computer was associated with a decreased risk regardless of timing (not late life but midlife: 0.52 [0.31-0.88]; late life but not midlife: 0.70 [0.56-0.88]; late life and midlife: 0.63 [0.51-0.79]). Craft activities were associated with a reduced risk of incident MCI only when carried out in late life but not midlife (0.58 [0.34-0.97]). Furthermore, engaging in a higher number of activities in late life was associated with a significantly reduced risk of incident MCI (any 2 activities: 0.72 [0.53-0.99], any 3: 0.55 [0.40-0.77], any 4: 0.44 [0.30-0.65], all 5: 0.57 [0.34-0.96]). Engaging in a higher number of mentally stimulating activities, particularly in late life, is associated with a decreased risk of MCI among community-dwelling older persons.

Identifiants

pubmed: 31292224
pii: WNL.0000000000007897
doi: 10.1212/WNL.0000000000007897
pmc: PMC6710000
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e548-e558

Subventions

Organisme : NIMH NIH HHS
ID : K01 MH068351
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG034676
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG016574
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG057708
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG006786
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

Références

J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):149-54
pubmed: 21677242
J Intern Med. 2004 Sep;256(3):183-94
pubmed: 15324362
J Gerontol B Psychol Sci Soc Sci. 2017 Jan;72(1):25-37
pubmed: 27974473
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Neurology. 2007 Nov 13;69(20):1911-20
pubmed: 17596582
Arch Neurol. 1991 Jul;48(7):725-8
pubmed: 1859300
Neurology. 2001 Dec 26;57(12):2236-42
pubmed: 11756603
JAMA. 2002 Feb 13;287(6):742-8
pubmed: 11851541
BMC Public Health. 2015 Oct 24;15:1089
pubmed: 26499254
J Gerontol B Psychol Sci Soc Sci. 2015 Mar;70(2):314-21
pubmed: 25190210
J Clin Exp Neuropsychol. 2003 Aug;25(5):625-33
pubmed: 12815500
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3440-5
pubmed: 11248097
J Lipid Res. 1990 Mar;31(3):545-8
pubmed: 2341813
Int Psychogeriatr. 2016 Nov;28(11):1791-1806
pubmed: 27502691
J Gerontol B Psychol Sci Soc Sci. 1999 May;54(3):P155-60
pubmed: 10363036
J Clin Exp Neuropsychol. 1998 Apr;20(2):194-200
pubmed: 9777473
Int Psychogeriatr. 2017 May;29(5):727-739
pubmed: 28067190
Neurology. 2009 Sep 15;73(11):854-61
pubmed: 19752452
Neuroepidemiology. 2008;30(1):58-69
pubmed: 18259084
J Gerontol A Biol Sci Med Sci. 2013 Feb;68(2):205-13
pubmed: 22879456
Neurology. 2006 Mar 28;66(6):821-7
pubmed: 16467493
J Intern Med. 2004 Sep;256(3):240-6
pubmed: 15324367
N Engl J Med. 2003 Jun 19;348(25):2508-16
pubmed: 12815136
Neurology. 2015 May 5;84(18):1854-61
pubmed: 25854867
Neurology. 1993 Nov;43(11):2412-4
pubmed: 8232972
JAMA Neurol. 2017 Mar 1;74(3):332-338
pubmed: 28135351

Auteurs

Janina Krell-Roesch (J)

From Translational Neuroscience and Aging Laboratory (J.K.-R., Y.E.G.) and Departments of Psychiatry and Psychology (Y.E.G.) and Neurology (Y.E.G.), Mayo Clinic, Scottsdale, AZ; Departments of Health Sciences Research (J.A.S., M.V., M.M. Mielke, W.K.K., Y.E.G.), Psychiatry and Psychology (M.M. Machulda), and Neurology (M.M. Mielke, D.S.K., R.C.P.), Mayo Clinic, Rochester, MN; and Institute of Sports and Sports Science (J.K.-R.), Karlsruhe Institute of Technology, Germany.

Jeremy A Syrjanen (JA)

From Translational Neuroscience and Aging Laboratory (J.K.-R., Y.E.G.) and Departments of Psychiatry and Psychology (Y.E.G.) and Neurology (Y.E.G.), Mayo Clinic, Scottsdale, AZ; Departments of Health Sciences Research (J.A.S., M.V., M.M. Mielke, W.K.K., Y.E.G.), Psychiatry and Psychology (M.M. Machulda), and Neurology (M.M. Mielke, D.S.K., R.C.P.), Mayo Clinic, Rochester, MN; and Institute of Sports and Sports Science (J.K.-R.), Karlsruhe Institute of Technology, Germany.

Maria Vassilaki (M)

From Translational Neuroscience and Aging Laboratory (J.K.-R., Y.E.G.) and Departments of Psychiatry and Psychology (Y.E.G.) and Neurology (Y.E.G.), Mayo Clinic, Scottsdale, AZ; Departments of Health Sciences Research (J.A.S., M.V., M.M. Mielke, W.K.K., Y.E.G.), Psychiatry and Psychology (M.M. Machulda), and Neurology (M.M. Mielke, D.S.K., R.C.P.), Mayo Clinic, Rochester, MN; and Institute of Sports and Sports Science (J.K.-R.), Karlsruhe Institute of Technology, Germany.

Mary M Machulda (MM)

From Translational Neuroscience and Aging Laboratory (J.K.-R., Y.E.G.) and Departments of Psychiatry and Psychology (Y.E.G.) and Neurology (Y.E.G.), Mayo Clinic, Scottsdale, AZ; Departments of Health Sciences Research (J.A.S., M.V., M.M. Mielke, W.K.K., Y.E.G.), Psychiatry and Psychology (M.M. Machulda), and Neurology (M.M. Mielke, D.S.K., R.C.P.), Mayo Clinic, Rochester, MN; and Institute of Sports and Sports Science (J.K.-R.), Karlsruhe Institute of Technology, Germany.

Michelle M Mielke (MM)

From Translational Neuroscience and Aging Laboratory (J.K.-R., Y.E.G.) and Departments of Psychiatry and Psychology (Y.E.G.) and Neurology (Y.E.G.), Mayo Clinic, Scottsdale, AZ; Departments of Health Sciences Research (J.A.S., M.V., M.M. Mielke, W.K.K., Y.E.G.), Psychiatry and Psychology (M.M. Machulda), and Neurology (M.M. Mielke, D.S.K., R.C.P.), Mayo Clinic, Rochester, MN; and Institute of Sports and Sports Science (J.K.-R.), Karlsruhe Institute of Technology, Germany.

David S Knopman (DS)

From Translational Neuroscience and Aging Laboratory (J.K.-R., Y.E.G.) and Departments of Psychiatry and Psychology (Y.E.G.) and Neurology (Y.E.G.), Mayo Clinic, Scottsdale, AZ; Departments of Health Sciences Research (J.A.S., M.V., M.M. Mielke, W.K.K., Y.E.G.), Psychiatry and Psychology (M.M. Machulda), and Neurology (M.M. Mielke, D.S.K., R.C.P.), Mayo Clinic, Rochester, MN; and Institute of Sports and Sports Science (J.K.-R.), Karlsruhe Institute of Technology, Germany.

Walter K Kremers (WK)

From Translational Neuroscience and Aging Laboratory (J.K.-R., Y.E.G.) and Departments of Psychiatry and Psychology (Y.E.G.) and Neurology (Y.E.G.), Mayo Clinic, Scottsdale, AZ; Departments of Health Sciences Research (J.A.S., M.V., M.M. Mielke, W.K.K., Y.E.G.), Psychiatry and Psychology (M.M. Machulda), and Neurology (M.M. Mielke, D.S.K., R.C.P.), Mayo Clinic, Rochester, MN; and Institute of Sports and Sports Science (J.K.-R.), Karlsruhe Institute of Technology, Germany.

Ronald C Petersen (RC)

From Translational Neuroscience and Aging Laboratory (J.K.-R., Y.E.G.) and Departments of Psychiatry and Psychology (Y.E.G.) and Neurology (Y.E.G.), Mayo Clinic, Scottsdale, AZ; Departments of Health Sciences Research (J.A.S., M.V., M.M. Mielke, W.K.K., Y.E.G.), Psychiatry and Psychology (M.M. Machulda), and Neurology (M.M. Mielke, D.S.K., R.C.P.), Mayo Clinic, Rochester, MN; and Institute of Sports and Sports Science (J.K.-R.), Karlsruhe Institute of Technology, Germany.

Yonas E Geda (YE)

From Translational Neuroscience and Aging Laboratory (J.K.-R., Y.E.G.) and Departments of Psychiatry and Psychology (Y.E.G.) and Neurology (Y.E.G.), Mayo Clinic, Scottsdale, AZ; Departments of Health Sciences Research (J.A.S., M.V., M.M. Mielke, W.K.K., Y.E.G.), Psychiatry and Psychology (M.M. Machulda), and Neurology (M.M. Mielke, D.S.K., R.C.P.), Mayo Clinic, Rochester, MN; and Institute of Sports and Sports Science (J.K.-R.), Karlsruhe Institute of Technology, Germany. geda.yonas@mayo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH